GeoVax Labs Granted Allowance By FDA To Start Phase 1 Clinical Trial For HIV/AIDS Therapeutic Vaccine

Links shared publicly online about this topic.

  • 1,275
    total visits

GeoVax Labs Granted Allowance By FDA To Start Phase 1 Clinical Trial For HIV/AIDS Therapeutic Vaccine

medicalnewstoday.com —

GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops, and tests innovative HIV/AIDS vaccines, is now allowed by the FDA (US Food and Drug Administration) to

View full resource at medicalnewstoday.com

Tags: Vaccination, HIV, AIDS, STD, Phase 1 Clinical Trial, Clinical Trial, FDA, Vaccine

  • Share

Most Recently Shared on March 31, 2010 at 6:15 pm By:

mnt_clinical MNT Clinical Trials

GeoVax Labs Granted Allowance By FDA To Start Phase 1 Clinical Trial For HIV/AIDS Therapeutic Vaccine http://mnt.to/3zFh #clinicaltrials

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT HIV/Aids MNT HIV/Aids

MNT Drug Approvals MNT Drug Approvals

MNT Vaccines MNT Vaccines

Advertisement